findmyKOL
Clinical trialNCT00307164CompletedPhase 2/PHASE3Interventional

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment167HIV InfectionsLipoatrophy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Puerto Rico-Aids Crs

    San Juan, Puerto Rico

United States
  • Alabama Therapeutics Crs

    Birmingham, Alabama, United States

  • Ucla Care Center Crs

    Los Angeles, California, United States

  • Usc Crs

    Los Angeles, California, United States

  • Stanford Crs

    Palo Alto, California, United States

  • Ucsd, Avrc Crs

    San Diego, California, United States

  • Harbor-Ucla Med. Ctr. Crs

    Torrance, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • the Ponce de Leon Ctr. Crs

    Atlanta, Georgia, United States

  • Univ. of Hawaii at Manoa, Leahi Hosp.

    Honolulu, Hawaii, United States

  • Rush Univ. Med. Ctr. Actg Crs

    Chicago, Illinois, United States

  • Indiana Univ. School of Medicine, Infectious Disease Research Clinic

    Indianapolis, Indiana, United States

  • Johns Hopkins Adult Aids Crs

    Baltimore, Maryland, United States

  • University of Minnesota, Actu

    Minneapolis, Minnesota, United States

  • Beth Israel Med. Ctr., Actu

    New York, New York, United States

  • Cornell Crs

    New York, New York, United States

  • Hiv Prevention & Treatment Crs

    New York, New York, United States

  • Ny Univ. Hiv/aids Crs

    New York, New York, United States

  • Trillium Health Actg Crs

    Rochester, New York, United States

  • Univ. of Rochester Actg Crs

    Rochester, New York, United States

  • Unc Aids Crs

    Chapel Hill, North Carolina, United States

  • Duke Univ. Med. Ctr. Adult Crs

    Durham, North Carolina, United States

  • Univ. of Cincinnati Crs

    Cincinnati, Ohio, United States

  • Case Crs

    Cleveland, Ohio, United States

  • Metrohealth Crs

    Cleveland, Ohio, United States

  • the Ohio State University Medical Center

    Columbus, Ohio, United States

  • Pitt Crs

    Pittsburgh, Pennsylvania, United States

  • the Miriam Hosp. Actg Crs

    Providence, Rhode Island, United States

  • Vanderbilt Therapeutics Crs

    Nashville, Tennessee, United States

  • University of Washington Aids Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2006
Primary completion
31 Dec 2008
Completion
31 Dec 2008
Last update posted
4 Nov 2021
Registered enrollment
167
Registry id
NCT00307164

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.